Monitoring the safety of herbal medicines

Drug Safety

Volumn 17, Issue 4, 1997, Pages 209-215

  Chan, Thomas Y K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT EXTRACT;

ANTICHOLINERGIC EFFECT; DRUG MONITORING; DRUG SAFETY; GINSENG; HERBAL MEDICINE; HONG KONG; HUMAN; INFORMATION SERVICE; INTOXICATION; MEDICINAL PLANT; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TEACHING HOSPITAL; WORLD HEALTH ORGANIZATION;

EID: 0030710449     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199717040-00001     Document Type: Review

References (49)

1. Chen K, Overview of use of traditional medicine in the Western Pacific Region. Proceedings of the Regional Workshop on Traditional Medicine, 13-15 Nov 1995, Hong Kong. Hong Kong; Department of Health, Hong Kong Government: 38-47
2. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246-52
3. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994; 309: 107-11
4. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996; 347: 569-73
5. Houlihan P. Traditional Chinese medicine becoming another health care option for Canadians. Can Med Assoc J 1993; 149: 482-3
6. Hien TT, White NJ. Qinghaosu [review]. Lancet 1993; 341: 603-8
7. Chan TYK, Critchley JAJH. Chinese herbal medicines and acute illness [editorial]. Intensive Care World 1994; 11: 140-2
8. Chan TYK. Chinese herbal medicines and the skin. Dermatol Pract 1995; 19-21
9. Phillipson JD, Anderson LA. Ethnopharmacology and Western medicine. J Ethnopharmacol 1989; 25: 61-72
10. Sutter MC, Wang YX. Recent cardiovascular drugs from Chinese medicinal drugs. Cardiovasc Res 1993; 27: 1891-901
11. Farnsworth NR. Ethnopharmacology and future drug development: the North American experience. J Ethnopharmacol 1993; 38: 145-52
12. D'Arcy PF. Adverse reactions and interactions with herbal medicines. Part 1. Adverse reactions. Adverse Drug React Toxicol Rev 1991; 10: 189-208
13. Huxtable RJ. The harmful potential of herbal and other products. Drug Saf 1990; 5 Suppl. 1: 126-36
14. De Smet PAGM. Toxicological outlook on the quality assurance of herbal remedies. In: De Smet PAGM, Keller K, Hänsel R, et al., editors. Adverse effects of herbal drugs. Vol. 1. Berlin: Springer-Verlag, 1992: 1-72
15. Chan TYK, Critchley JAJH. Usage and adverse effects of some Chinese herbal medicines. Hum Exp Toxicol 1996; 15: 5-12
16. Chan TYK. Monitoring the safety of Chinese herbal medicines in Hong Kong [letter]. Ann Pharmacother 1996; 30: 1039-40
17. De Smet PAGM. Legislatory outlook on the safety of herbal remedies. In: De Smet PAGM, Keller K, Hänsel R, et al., editors. Adverse effects of herbal drugs. Vol. 2. Berlin: Springer-Verlag, 1993: 1-90
18. Ernst E. Complementary medicine: common misconceptions. J R Soc Med 1995; 88: 244-7
19. Moulds RFW, McNeil JJ. Herbal preparations: to regulate or not to regulate? Med J Aust 1988; 149: 573-4
20. Chang HM, But PPH. Pharmacology and applications of Chinese materia medica. Vol. 1 and Vol. 2. Singapore: World Scientific, 1987
21. De Smet PAGM. Health risks of herbal remedies. Drug Saf 1995; 13: 81-93
22. But PPH. Herbal poisoning caused by adulterants or erroneous substitutes. J Trop Med Hyg 1994; 97: 371-4
23. Ng THK, Chan YW, Yu YL, et al. Encephalopathy and neuropathy following ingestion of a Chinese herbal broth containing podophyllin. J Neurol Sci 1991; 101: 107-13
24. Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387-91
25. Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994; 121: 729-35
26. Zhang DZ. Development of traditional Chinese medicine and pharmacology in Hong Kong [in Chinese]. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 1992; 12: 245
27. Report of the Working Party on Chinese Medicine. Hong Kong: Government Printer, 1994
28. Chan TYK, Critchley JAJH, Chan JCN, et al. The Drug and Poisons Information Bureau al the Chinese University of Hong Kong. J Hong Kong Med Assoc 1993; 45: 202-5
29. Lau MSW, Chan TYK, Tomlinson B, et al. Role of the Drug and Poisons Information Bureau in monitoring the safety of Chinese herbal medicines in Hong Kong. J Natural Toxins 1995; 4: 203-6
30. Chan TYK, Chan AYW, Critchley JAJH. Hospital admissions due to adverse reactions to Chinese herbal medicines. J Trop Med Hyg 1992; 95: 296-8
31. Chan TYK, Chan JCN, Tomlinson B, et al. Poisoning by Chinese herbal medicines in Hong Kong: a hospital-based study. Vet Hum Toxicol 1994; 36: 546-7
32. Chan TYK, Lee KKC, Chan AYW, et al. Poisoning due to Chinese proprietary medicines in Hong Kong. Hum Exp Toxicol 1995; 14: 434-6
33. Yuan HN, Tan DJ. A review of the literature of the adverse effects of Chinese herbal drugs as published in major medical and pharmacological journals in China in 1990 [in Chinese]. Chung Kuo Chung Yao Tsa Chih 1991; 16: 628-34
34. Du S, Cao F, Lei S. A survey of adverse effects of Chinese herbal drugs in China, 1915-1990 [in Chinese]. Chung Kuo Chung Yao Tsa Chih 1992; 17: 435-38
35. Zhang SC, Li SZ, Gao XC, et al. The adverse effects of the preparations of the active principles of Chinese herbal drugs [in Chinese]. Chung Kuo Chung Yao Tsa Chih 1993; 18: 387-91
36. Ng YB. A review of 652 cases of poisoning by the aconite roots in China in the past 30 years (author's translation) [in Chinese]. Kiangsu Chung Yei 1988; 12: 39-42
37. Chan TYK, Critchley JAJH, Chan MTV, et al. Drug overdosage and other poisoning in Hong Kong: the Prince of Wales Hospital (Shatin) experience. Hum Exp Toxicol 1994; 13: 512-5
38. Chan TYK, Chan LY, Tam LS, et al. Neurotoxicity following the ingestion of a Chinese medicinal plant, Alocasia macrorrhiza. Hum Exp Toxicol 1995; 14: 727-8
39. Kwok JC. A dictionary of poisonous Chinese herbal medicines. Tianjian: Tianjian Technology Translation Publishing, 1992
40. Chan TYK. The prevalence, use and harmful potentials of some Chinese herbal medicines in babies and children. Vet Hum Toxicol 1994; 36: 238-40
41. Chan TYK. Aconitine poisoning: a global perspective. Vet Hum Toxicol 1994; 36: 115-7
42. Chan TYK. Anticholingeric poisoning due to Chinese herbal medicines. Vet Hum Toxicol 1995; 37: 156-7
43. Chan TYK, Critchley JAJH. The systems for monitoring adverse drug reactions in Hong Kong. Pharmacoepidemiol Drug Saf 1993; 2: 145-8
44. Stone J. Regulating complementary medicine [editorial]. BMJ 1996; 312: 1492-3
45. Ernst E, Abbot NC. Research priorities in complementary medicine [letter]. BMJ 1996; 312: 1481-8
46. Perharic L, Shaw D, Colbridge M, et al. Toxicological problems resulting from exposure to traditional remedies and food supplements. Drug Saf 1994; 11: 284-94
47. Mills SY. European pilot studies are under way [letter]. BMJ 1995; 311: 1570
48. Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA 1995; 273: 607-9
49. Edwards R. WHO project is under way [letter]. BMJ 1995; 311: 1569-70